Cubicin - Newsfeeds

Cubist Pharmaceuticals' Antibiotic Programs Featured in 47 Presentations at 50th ICAAC: CUBICIN® (daptomycin for injection), as well as the company's clinical and preclinical antibiotic programs. Included are 43 poster presentations and 4 slide presentations. Highlights, including brief descriptions ...
Cubist Pharmaceuticals to Host Product Pipeline Investor and Analyst Event: the company will provide market-based perspective on growth factors supporting the continued historic growth trajectory for CUBICIN® (daptomycin for injection). Also, the company will provide an overview of its ...
Cubist to add 100 jobs: Cubist is a biopharmaceutical company best known for Cubicin, an antibiotic that treats patients with sometimes life-threatening infections. The firm employs more than 600 people - about 370 in Massachusetts.
Cubist Pharma Promotes Steven Gilman To EVP, Research And Development And Chief Scientific ...: The company markets CUBICIN, the first antibiotic in a new class of anti-infectives called lipopeptides in the United States.
Cubist Pharmaceuticals’ Antibiotic Programs Featured In 47 Presentations At 50th ICAAC: CUBICIN® (daptomycin for injection), as well as the company’s clinical and preclinical antibiotic programs. Included are 43 poster presentations and 4 slide presentations.
Cubist Pharmaceuticals to Host Product Pipeline Investor and Analyst Event: the company will provide market-based perspective on growth factors supporting the continued historic growth trajectory for CUBICIN® (daptomycin for injection). Also, the company will provide an overview of its ...
Cubist Pharmaceuticals Announces Promotion of Steven C. Gilman, Ph.D., to EVP, Research and ...: Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides. The Cubist clinical product pipeline currently consists of a Phase 2 program, added with ...
Cubist expanding in Lexington, adding jobs: the company’s antibiotic drug Cubicin prompted the U.S. Food and Drug Administration to send letters to patients and doctors warning them about the risk of developing a serious form of pneumonia , linked to Cubicin ...
Cubist Pharmaceuticals Prepares for Continued Growth: Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides. The Cubist clinical product pipeline currently consists of a Phase 2 program, added with ...
Cubist Pharmaceuticals to Present at September Investor Conferences: Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides. The Cubist clinical product pipeline currently consists of a Phase 2 program, added with ...

Cubist Pharmaceuticals' Antibiotic Programs Featured in 47 Presentations at 50th ICAAC: CUBICIN(R) (daptomycin for injection), as well as the company's clinical and preclinical antibiotic programs. Included are 43 poster presentations and 4 slide presentations. -- 17 focus on daptomycin or related ...
Cubist Pharma To Oppose Teva's Move To Amend Answer In Patent Litigation - Update: and internationally under the brand name Cubicin (daptomycin for injection) as therapy for serious skin and bloodstream infections caused by certain Gram-positive bacteria. In the motion, the Teva defendants seek leave ...
Cubist Pharmaceuticals to Oppose Teva's Attempt to Add Inequitable Conduct Defense in Patent ...: Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. Cubist also promotes MERREM® I.V. (meropenem for injection) in the U.S. under an agreement ...
Trius Moves Antibiotic Toward Next Trial As Deficit Rises: s Cubicin. The company has been supported largely by venture capital to date. It has raised $68.2 million across three funding events, one in each of the past three years. Sofinnova Venture Partners, InterWest Partners ...
PolyMedix Successfully Completes Phase 1B Clinical ...: ... current antibiotics; Faster acting than many antibiotics; and Activity against drug-resistant bacteria, including clinical isolates of multiple vancomycin-, methicillin-, and daptomycin-resistant strains. About PolyMedix, Inc. PolyMedix is a ...
Cubist Pharmaceuticals to End Development of CB-500,929: Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. Cubist also promotes MERREM® I.V. (meropenem for injection) in the U.S. under an agreement with AstraZeneca.
www.StockMarketingInc.com: Tuesday's Pick!! GSAE - Green Star ...: Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. In July 2008, Cubist entered into an agreement with AstraZeneca to promote their established antibiotic, MERREM(R) I.
What We Like About Cubist Pharma: Cubist has one marketed product, an intravenous (IV) antibiotic, CUBICIN (daptomycin for injection). CUBICIN is approved in the United States for the treatment of complicated skin and skin structure infections (cSSSI), caused by Staphylococcus aureus ...
Cubist calls surge with buyout rumors: On Oct. 16, the biotechnology company reduced the sales forecast for Cubicin, its only product on the market. The shares are climbing today amid unconfirmed takeover rumors and after bouncing off an old support level around $16.70. They need to climb ...
Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals ...: Cubist Pharmaceuticals, Inc., a biopharmaceutical company is engaged in the research, development and commercialization of drug products for the acute care environments. The company s lead product, CUBICIN (daptomycin for injection), an intravenous ...

Looking for a District of Columbia Cubicin lawyer? Get in touch with one of our District of Columbia Cubicin lawyers now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 Next

Need A Cubicin Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Cubicin Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Cubicin Information

Click to View Our Legal Resources

Looking for a District of Columbia Cubicin lawyer? Get in touch with one of our District of Columbia Cubicin lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-061639

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Cubicin Click to select a Legal Issue

Close (x)

Find Legal Help for Your Cubicin Case - Submit Your Information Below

Do you need legal assistance with your Cubicin case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Cubicin Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.